Our commitment to transparency

LEO Pharma is transparent about information and results from our clinical trials.

LEO Pharma has a long-standing commitment to being transparent about our clinical trials. We consider it both an ethical and scientific responsibility to register our trials on publicly available databases and report the results, whether positive or negative.

We want patients and healthcare professionals to be able to take informed decisions about treatments. To support this, we make information about our clinical trials available through a variety of ways. We also fulfil all obligations to the relevant health authorities, such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).